Status:
RECRUITING
Vibrometer Based Pulse Wave Analysis for Arterial Stiffness and Ischemic Heart Disease Risk Assessment
Lead Sponsor:
HJN Sverige AB/Neko Health
Conditions:
Hypertension
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
This clinical investigation will evaluate a novel contactless technology for assessing arterial stiffness and explore its potential in assessment of risk for and development of cardiovascular disease....
Detailed Description
Arterial stiffness, commonly assessed as pulse wave velocity (PWV), is a marker of aging of the cardio-vascular system strongly associated with hypertension and increased risk for and development of c...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Adult patients that are part of the regular healthcare patient flow at the investigational sites, or as separately invited to participate in this investigation.
- Patients with signed informed consent
- Exclusion criteria:
- Cognitive impairment
- Patients unable to understand the oral and written study information in Swedish or English
- Other severe disorder or terminal disease, e.g. infection/sepsis, severe COPD or metastatic cancers.
- Patients unable to provide an informed consent
Exclusion
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
8000 Patients enrolled
Trial Details
Trial ID
NCT06984211
Start Date
February 1 2023
End Date
February 1 2026
Last Update
May 22 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Atrium Health Care Centre
Stockholm, Sweden
2
Neko Health Centre, Regeringsgatan
Stockholm, Sweden
3
Neko Health Centre, Sibyllegatan
Stockholm, Sweden